Superoxide dismutase 1 loss disturbs intracellular redox signaling, resulting in global age-related pathological changes

Biomed Res Int. 2014:2014:140165. doi: 10.1155/2014/140165. Epub 2014 Sep 8.

Abstract

Aging is characterized by increased oxidative stress, chronic inflammation, and organ dysfunction, which occur in a progressive and irreversible manner. Superoxide dismutase (SOD) serves as a major antioxidant and neutralizes superoxide radicals throughout the body. In vivo studies have demonstrated that copper/zinc superoxide dismutase-deficient (Sod1(-/-)) mice show various aging-like pathologies, accompanied by augmentation of oxidative damage in organs. We found that antioxidant treatment significantly attenuated the age-related tissue changes and oxidative damage-associated p53 upregulation in Sod1(-/-) mice. This review will focus on various age-related pathologies caused by the loss of Sod1 and will discuss the molecular mechanisms underlying the pathogenesis in Sod1(-/-) mice.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aging / drug effects
  • Aging / pathology*
  • Animals
  • Antioxidants / pharmacology
  • Humans
  • Intracellular Space / metabolism*
  • Oxidation-Reduction / drug effects
  • Signal Transduction* / drug effects
  • Superoxide Dismutase / deficiency
  • Superoxide Dismutase / metabolism*
  • Superoxide Dismutase-1

Substances

  • Antioxidants
  • SOD1 protein, human
  • Sod1 protein, mouse
  • Superoxide Dismutase
  • Superoxide Dismutase-1